Get started
Coloplast ASColoplast ASColoplast AS

Coloplast AS

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

CLPBF chart

Upcoming earnings

Next report date
Report period
Q2 2024
EPS estimate
0.84USD
Revenue estimate
‪966.11 M‬USD

Key stats

Market capitalization
‪27.92 B‬USD
Dividend yield (indicated)
2.43%
Price to earnings Ratio (TTM)
38.92
Basic EPS (TTM)
3.35USD
Net income (FY)
‪676.32 M‬USD
Revenue (FY)
‪3.46 B‬USD
Shares float
‪141.60 M‬
Beta (1Y)
0.36

About COLOPLAST B A/S

Sector
Health Technology
Industry
Medical Specialties
CEO
Kristian Villumsen
Website
coloplast.com
Headquarters
Humlebaek
Employees (FY)
‪15.69 K‬
Founded
1957
ISIN
DK0060448595
FIGI
BBG000BMB5X8
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CLPBF is 119.50 USD — it has decreased by 4.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Coloplast AS stocks are traded under the ticker CLPBF.
Coloplast AS is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
CLPBF stock is 5.02% volatile and has beta coefficient of 0.36. Check out the list of the most volatile stocks — is Coloplast AS there?
CLPBF earnings for the last quarter are 0.81 USD per share, whereas the estimation was 0.88 USD resulting in a −7.85% surprise. The estimated earnings for the next quarter are 0.82 USD per share. See more details about Coloplast AS earnings.
Coloplast AS revenue for the last quarter amounts to ‪880.36 M‬ USD despite the estimated figure of ‪906.59 M‬ USD. In the next quarter revenue is expected to reach ‪979.00 M‬ USD.
Yes, you can track Coloplast AS financials in yearly and quarterly reports right on TradingView.
CLPBF stock has fallen by 7.49% compared to the previous week, the month change is a 8.85% fall, over the last year Coloplast AS has showed a 16.87% decrease.
CLPBF net income for the last quarter is ‪179.40 M‬ USD, while the quarter before that showed ‪173.78 M‬ USD of net income which accounts for 3.24% change. Track more Coloplast AS financial stats to get the full picture.
Today Coloplast AS has the market capitalization of ‪27.74 B‬, it has decreased by 1.26% over the last week.
Coloplast AS dividend yield was 2.81% in 2023, and payout ratio reached 94.57%. The year before the numbers were 2.58% and 90.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, CLPBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Coloplast AS stock right from TradingView charts — choose your broker and connect to your account.
CLPBF reached its all-time high on Nov 2, 2012 with the price of 217.80 USD, and its all-time low was 49.00 USD and was reached on Dec 26, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪15.69 K‬ employees. See our rating of the largest employees — is Coloplast AS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Coloplast AS technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Coloplast AS stock shows the sell signal. See more of Coloplast AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Coloplast AS future price: according to them, CLPBF price has a max estimate of 151.58 USD and a min estimate of 100.10 USD. Read a more detailed Coloplast AS forecast: see what analysts think of Coloplast AS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Coloplast AS EBITDA is ‪1.18 B‬ USD, and current EBITDA margin is 32.07%. See more stats in Coloplast AS financial statements.